This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Interleukin-5 (IL5), N-His-GST
Product Overview
BioVenic's Recombinant Equine Interleukin-5 (IL5), N-His-GST is a recombinant protein expressed from E.coli expression system. Its predicted molecular weight is 43.1 kDa. The purity is greater than 90% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL). It can be used as a positive control or as an immunogen.
Specifications
Target Information
Interleukin 5 (IL-5) is an interleukin produced by type-2 T helper cells and mast cells. Interleukin 5 is encoded by the IL5 gene in horses. IL5 is the key cytokine for eosinophils. IL-5 binds to the interleukin-5 receptor, promoting the growth of B cells and increasing the secretion of immunoglobulins, primarily IgA. Targeting IL5 by vaccination has been shown to reduce disease symptoms in horses.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10 mM PBS (pH 7.4) to a concentration of 0.1-1.0 mg/mL. Aliquote the reconstituted solution to minimise freeze-thaw cycles.